Bank Pictet & Cie Europe AG raised its position in Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 176.6% during the 3rd quarter, Holdings Channel reports. The firm owned 2,545 shares of the semiconductor company’s stock after acquiring an additional 1,625 shares during the quarter. Bank Pictet & Cie Europe AG’s holdings in Synopsys were worth $1,107,000 at the end of the most recent reporting period.
A number of other hedge funds have also made changes to their positions in SNPS. Norway Savings Bank raised its stake in shares of Synopsys by 7.3% during the 3rd quarter. Norway Savings Bank now owns 2,211 shares of the semiconductor company’s stock worth $962,000 after buying an additional 150 shares during the last quarter. Sumitomo Mitsui DS Asset Management Company Ltd boosted its position in shares of Synopsys by 2.7% in the 3rd quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 58,644 shares of the semiconductor company’s stock worth $25,507,000 after buying an additional 1,534 shares in the last quarter. Midway Capital Research & Management grew its stake in Synopsys by 0.6% in the 3rd quarter. Midway Capital Research & Management now owns 6,549 shares of the semiconductor company’s stock valued at $2,848,000 after acquiring an additional 40 shares during the last quarter. Retail Employees Superannuation Pty Ltd as trustee for Retail Employees Superannuation Trust grew its stake in Synopsys by 21.3% in the 3rd quarter. Retail Employees Superannuation Pty Ltd as trustee for Retail Employees Superannuation Trust now owns 31,144 shares of the semiconductor company’s stock valued at $13,546,000 after acquiring an additional 5,476 shares during the last quarter. Finally, Investment Research Partners LLC grew its stake in Synopsys by 24.0% in the 3rd quarter. Investment Research Partners LLC now owns 693 shares of the semiconductor company’s stock valued at $301,000 after acquiring an additional 134 shares during the last quarter. Hedge funds and other institutional investors own 85.47% of the company’s stock.
Insider Activity
In related news, CEO Sassine Ghazi sold 14,604 shares of the firm’s stock in a transaction that occurred on Tuesday, September 15th. The shares were sold at an average price of $374.88, for a total transaction of $5,474,747.52. Following the sale, the chief executive officer owned 76,865 shares in the company, valued at approximately $28,815,151.20. This trade represents a 15.97% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO Sudhindra Kankanwadi sold 9,170 shares of the firm’s stock in a transaction that occurred on Tuesday, October 6th. The stock was sold at an average price of $500.00, for a total transaction of $4,585,000.00. Following the sale, the chief financial officer owned 22,717 shares in the company, valued at approximately $11,358,500. This trade represents a 28.76% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders sold 117,163 shares of company stock worth $51,366,457. Corporate insiders own 0.56% of the company’s stock.
Wall Street Analyst Weigh In
A number of equities analysts have issued reports on the stock. HSBC cut shares of Synopsys from a “buy” rating to a “reduce” rating in a research report on Friday, September 25th. Benchmark reiterated a “buy” rating and issued a $570.00 price target on shares of Synopsys in a research report on Thursday, August 27th. Robert W. Baird upgraded shares of Synopsys from a “neutral” rating to an “outperform” rating and increased their price target for the company from $558.00 to $560.00 in a research report on Thursday, August 27th. Morgan Stanley dropped their price objective on shares of Synopsys from $525.00 to $500.00 and set an “equal weight” rating for the company in a research note on Wednesday, August 19th. Finally, Weiss Ratings cut shares of Synopsys from a “hold (c)” rating to a “hold (c-)” rating in a research note on Friday, September 11th. One research analyst has rated the stock with a Strong Buy rating, twenty-one have assigned a Buy rating and four have given a Hold rating to the stock. According to MarketBeat.com, Synopsys has an average rating of “Moderate Buy” and an average price target of $571.78.
Read Our Latest Research Report on Synopsys
Synopsys Price Performance
Synopsys stock traded down $9.19 during midday trading on Tuesday, reaching $445.39. 590,745 shares of the company were exchanged, compared to its average volume of 2,050,733. The firm’s 50-day simple moving average is $428.42 and its 200-day simple moving average is $442.33. Synopsys, Inc. has a 1 year low of $362.55 and a 1 year high of $539.48. The company has a market capitalization of $85.35 billion, a price-to-earnings ratio of 78.65, a P/E/G ratio of 1.85 and a beta of 1.21. The company has a debt-to-equity ratio of 0.29, a quick ratio of 1.24 and a current ratio of 1.34.
Synopsys (NASDAQ:SNPS – Get Free Report) last released its earnings results on Wednesday, August 26th. The semiconductor company reported $3.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.67 by $0.24. Synopsys had a net margin of 11.43% and a return on equity of 6.24%. The company had revenue of $2.48 billion for the quarter, compared to analyst estimates of $2.44 billion. During the same period in the prior year, the firm earned $3.39 EPS. The firm’s quarterly revenue was up 42.4% on a year-over-year basis. Synopsys has set its Q4 2026 guidance at 4.100-4.160 EPS and its FY 2026 guidance at 15.040-15.100 EPS. On average, analysts anticipate that Synopsys, Inc. will post 10.97 EPS for the current year.
Synopsys declared that its Board of Directors has authorized a stock buyback plan on Monday, October 5th that allows the company to repurchase $1.00 billion in shares. This repurchase authorization allows the semiconductor company to repurchase up to 1.1% of its stock through open market purchases. Stock repurchase plans are generally an indication that the company’s board of directors believes its stock is undervalued.
Synopsys Company Profile
Synopsys, Inc is an electronic design automation (EDA) and semiconductor intellectual property company serving the global semiconductor and electronics industries. Its software helps engineers design, verify, test and manufacture advanced integrated circuits and electronic systems.
The company’s products and services support digital and analog design, functional verification, design-for-test, manufacturing and semiconductor engineering workflows. Synopsys also provides reusable semiconductor IP, including processor cores, interface technologies, security solutions and other components used in system-on-chip designs.
In addition to its semiconductor design offerings, Synopsys provides software development and application security tools intended to help organizations identify and manage vulnerabilities and risks across the software development lifecycle.
See Also
- Five stocks we like better than Synopsys
- IonQ’s Bold Expansion Could Leave Shareholders Paying the Price
- Powering Up: Applied Digital Execs Buy $6.7M in Stock
- Chip Stocks Are Sliding—Why Is Smart Money Buying?
- Adults Are Fueling a Toy Boom—These 4 Stocks Could Cash In
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
